MTOR and gastric cancer: found that IL-8 from GC-MSCs could induce PD-L1 expression in GC cells through STAT3/mTOR-c-Myc signaling axis, thereby causing GC cells to develop resistance to the cytotoxicity of CD8+ T cells.